axiom-covid-array-markers-header

We have launched the Applied Biosystems Axiom Human Genotyping SARS-CoV-2 Research Array.

Features include:

  • Large GWAS module (>820,000) with research markers associated with underlying conditions such as lung disease, diabetes, cardiovascular disease, and respiratory distress
  • SARS-CoV-2-specific research module that includes markers for:
    --Various cytokines and pathways (e.g., NOTCH signaling pathways, RAAS) associated with immunology, inflammation, and respiratory distress
    --ACE2 and TMPRSS2 genes associated with cell surface receptors and virus entry facilitators
    --Structural and non-structural proteins predicted or observed to interact with viral proteins
  • Pharmacogenomic markers for research into druggable targets and adverse drug reactions
  • Variants covering various blood groups including ABO

For more information, complete the short form below and a technical sales specialist will contact you.

*
*
*
*
*
*

*
 0-6 months
 6-9 months
 >9 months
 None
*
 <5000
 5000-20000
 >20000
*
 Yes
 No
 
 
Note: By participating in this event and providing your input, you represent and warrant that you have sufficient rights to make such input freely available for Thermo Fisher’s use.  You understand and agree that Thermo Fisher will have the right to freely use any information or other input that you provide to develop, modify or improve their microarray products, without further notice, accounting or recompense to you and that, as between you and Thermo Fisher, all rights in any such microarray products belong and will continue to belong exclusively to Thermo Fisher.